ALB and neoplasm: In the U87MG-shSPARC tumor model, 26 days after first drug treatment, CDDP-treated mice showed significantly reduced tumor growth than the PBS group (Figure 3b, p < 0.001), but HSA–CDDP-treated mice showed no difference in tumor growth to PBS.